The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119958633 11995863 3 F 2014 20160713 20160203 20160719 EXP JP-SA-2016SA018192 AVENTIS 55.00 YR A F Y 0.00000 20160719 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119958633 11995863 1 PS DOCETAXEL. DOCETAXEL 1 Unknown U UNK 20449
119958633 11995863 2 SS FLUOROURACIL. FLUOROURACIL 1 Unknown U UNK 0
119958633 11995863 3 SS CISPLATIN. CISPLATIN 1 Unknown U UNK 0
119958633 11995863 4 C CETUXIMAB CETUXIMAB 1 0
119958633 11995863 5 C PACLITAXEL. PACLITAXEL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119958633 11995863 1 Skin cancer metastatic
119958633 11995863 2 Skin cancer metastatic
119958633 11995863 3 Skin cancer metastatic
119958633 11995863 4 Chemotherapy
119958633 11995863 5 Chemotherapy

Outcome of event

Event ID CASEID OUTC COD
119958633 11995863 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
119958633 11995863 Abdominal distension
119958633 11995863 Abdominal pain lower
119958633 11995863 Abdominal tenderness
119958633 11995863 Cholangitis
119958633 11995863 Constipation
119958633 11995863 Decreased appetite
119958633 11995863 Dehydration
119958633 11995863 Diarrhoea
119958633 11995863 Duodenal stenosis
119958633 11995863 Gastric dilatation
119958633 11995863 Gastrointestinal mucosal disorder
119958633 11995863 Gastroptosis
119958633 11995863 Malabsorption
119958633 11995863 Malaise
119958633 11995863 Nausea
119958633 11995863 Neutropenia
119958633 11995863 Superior mesenteric artery syndrome
119958633 11995863 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119958633 11995863 1 201406 0
119958633 11995863 2 201406 0
119958633 11995863 3 201406 0
119958633 11995863 4 201405 0
119958633 11995863 5 201405 0